Henriett Butz, Ph.D. - Publications

Affiliations: 
2010 Clinical Medicine Semmelweis Egyetem, Hungary 
Area:
Medicine and Surgery

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Németh K, Mészáros K, Szabó B, Butz H, Arányi T, Szabó PT. A relative quantitation method for measuring DNA methylation and hydroxymethylation using guanine as an internal standard. Analytical Methods : Advancing Methods and Applications. 13: 4614-4622. PMID 34528637 DOI: 10.1039/d1ay00897h  1
2021 Sarkadi B, Liko I, Nyiro G, Igaz P, Butz H, Patocs A. Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma. Cancers. 13. PMID 34439371 DOI: 10.3390/cancers13164219  1
2021 Krokker L, Szabó B, Németh K, Tóháti R, Sarkadi B, Mészáros K, Patócs A, Butz H. Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors. Pathology Oncology Research : Por. 27: 640676. PMID 34257605 DOI: 10.3389/pore.2021.640676  1
2021 Krokker L, Patócs A, Butz H. Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors. Genes. 12. PMID 34066712 DOI: 10.3390/genes12050698  1
2021 Pócza T, Grolmusz VK, Papp J, Butz H, Patócs A, Bozsik A. Germline Structural Variations in Cancer Predisposition Genes. Frontiers in Genetics. 12: 634217. PMID 33936164 DOI: 10.3389/fgene.2021.634217  1
2021 Turai PI, Nyírő G, Butz H, Patócs A, Igaz P. MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma. Cancers. 13. PMID 33810219 DOI: 10.3390/cancers13071522  1
2021 Butz H, Papp J, Bozsik A, Krokker L, Pócza T, Oláh E, Patócs A. Application of Multilayer Evidence for Annotation of C-Terminal Variants. Cancers. 13. PMID 33672545 DOI: 10.3390/cancers13040881  1
2021 Butz H, Blair J, Patócs A. Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes. Endocrine. PMID 33570725 DOI: 10.1007/s12020-021-02636-x  1
2020 Kövesdi A, Kurucz PA, Nyírő G, Darvasi O, Patócs A, Butz H. Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors. Cancers. 12. PMID 32887459 DOI: 10.3390/Cancers12092488  1
2020 Bozsik A, Pócza T, Papp J, Vaszkó T, Butz H, Patócs A, Oláh E. Complex Characterization of Germline Large Genomic Rearrangements of the and Genes in High-Risk Breast Cancer Patients-Novel Variants from a Large National Center. International Journal of Molecular Sciences. 21. PMID 32629901 DOI: 10.3390/Ijms21134650  1
2020 Szabó B, Németh K, Mészáros K, Szücs N, Czirják S, Reiniger L, Rajnai H, Krencz I, Karászi K, Krokker L, Patócs A, Butz H. Demethylation status of somatic DNA extracted from pituitary neuroendocrine tumors indicates proliferative behavior. The Journal of Clinical Endocrinology and Metabolism. PMID 32232382 DOI: 10.1210/Clinem/Dgaa156  1
2020 Butz H, Nyírő G, Kurucz PA, Likó I, Patócs A. Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice. Human Genetics. PMID 32222824 DOI: 10.1007/S00439-020-02148-0  1
2020 Sarkadi B, Meszaros K, Krencz I, Canu L, Krokker L, Zakarias S, Barna G, Sebestyen A, Papay J, Hujber Z, Butz H, Darvasi O, Igaz P, Doczi J, Luconi M, et al. Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. Cancers. 12. PMID 32150977 DOI: 10.3390/Cancers12030599  1
2019 Rzepiel A, Kutszegi N, Gézsi A, Sági JC, Egyed B, Péter G, Butz H, Nyírő G, Müller J, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia. Journal of Translational Medicine. 17: 372. PMID 31727091 DOI: 10.1186/S12967-019-2114-X  1
2019 Butz H, Patócs A. Brief Summary of the Most Important Molecular Genetic Methods (PCR, qPCR, Microarray, Next-Generation Sequencing, etc.). Experientia Supplementum (2012). 111: 33-52. PMID 31588527 DOI: 10.1007/978-3-030-25905-1_4  1
2019 Bertalan R, Bencsik Z, Mezei P, Vajda Z, Butz H, Patócs A. Novel frameshift mutation of the NR0B1(DAX1) in two tall adult brothers. Molecular Biology Reports. PMID 31280422 DOI: 10.1007/S11033-019-04688-9  1
2019 Butz H, Patócs A. MicroRNAs in endocrine tumors. Ejifcc. 30: 146-164. PMID 31263390  1
2019 Németh K, Darvasi O, Likó I, Szücs N, Czirják S, Reiniger L, Szabó B, Krokker L, Pállinger É, Igaz P, Patócs A, Butz H. Comprehensive analysis of circulating microRNAs in plasma of patients with pituitary adenomas. The Journal of Clinical Endocrinology and Metabolism. PMID 31112271 DOI: 10.1210/Jc.2018-02479  1
2019 Kövesdi A, Tóth M, Butz H, Szücs N, Sármán B, Pusztai P, Tőke J, Reismann P, Fáklya M, Tóth G, Somogyi A, Borka K, Erdei A, Nagy EV, Deák V, et al. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine. PMID 31044390 DOI: 10.1007/S12020-019-01932-X  1
2019 Krokker L, Nyírő G, Reiniger L, Darvasi O, Szücs N, Czirják S, Tóth M, Igaz P, Patócs A, Butz H. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma. Neurochemical Research. PMID 30945144 DOI: 10.1007/S11064-019-02789-2  1
2018 Lichner Z, Saleeb R, Butz H, Ding Q, Nofech-Mozes R, Riad S, Farag M, Varkouhi AK, Dos Santos CC, Kapus A, Yousef GM. Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800596R. PMID 30148679 DOI: 10.1096/Fj.201800596R  1
2018 Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H. Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas. Oncotarget. 9: 29180-29192. PMID 30018744 DOI: 10.18632/Oncotarget.25650  1
2018 Butz H, Ding Q, Nofech-Mozes R, Lichner Z, Ni H, Yousef GM. Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis. Oncotarget. 9: 4661-4674. PMID 29435133 DOI: 10.18632/Oncotarget.23163  1
2018 Sarkadi B, Grolmusz VK, Butz H, Kövesdi A, Likó I, Nyirő G, Igaz P, Patócs A. [Evolution of molecular genetic methods in the clinical diagnosis of hereditary endocrine tumour syndromes]. Orvosi Hetilap. 159: 285-292. PMID 29429353 DOI: 10.1556/650.2018.31036  1
2018 Németh K, Darvasi O, Szücs N, Czirják S, Butz H. [The role of miRNAs in the pathogenesis of pituitary adenomas]. Orvosi Hetilap. 159: 252-259. PMID 29429349 DOI: 10.1556/650.2018.30922  1
2018 Solarski M, Rotondo F, Foulkes W, Priest JR, Syro LV, Butz H, Cusimano M, Kovacs K. DICER1 gene mutations in endocrine tumors. Endocrine-Related Cancer. PMID 29330195 DOI: 10.1530/Erc-17-0509  1
2017 Darvasi O, Szabo PM, Nemeth K, Szabo K, Spisak S, Liko I, Czirjak S, Racz K, Igaz P, Patocs A, Butz H. Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas. Pathology Oncology Research : Por. PMID 29043608 DOI: 10.1007/S12253-017-0330-3  1
2017 Dávid A, Butz H, Halász Z, Török D, Nyirő G, Muzsnai Á, Csákváry V, Luczay A, Sallai Á, Hosszú É, Felszeghy E, Tar A, Szántó Z, Fekete GL, Kun I, et al. [The prevalence of SHOX gene deletion in children with idiopathic short stature. A multicentric study]. Orvosi Hetilap. 158: 1351-1356. PMID 28823207 DOI: 10.1556/650.2017.30829  1
2017 Perge P, Butz H, Pezzani R, Bancos I, Nagy Z, Pálóczi K, Nyírő G, Decmann Á, Pap E, Luconi M, Mannelli M, Buzás EI, Tóth M, Boscaro M, Patócs A, et al. Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Scientific Reports. 7: 5474. PMID 28710381 DOI: 10.1038/S41598-017-05777-0  1
2017 Decmann Á, Perge P, Nagy Z, Butz H, Patócs A, Igaz P. [Circulating microRNAs in the diagnostics of endocrine neoplasms]. Orvosi Hetilap. 158: 483-490. PMID 28347154 DOI: 10.1556/650.2017.30708  1
2017 Lichner Z, Saleeb R, Butz H, Nofech-Mozes R, Riad S, Farag M, Kapus A, Yousef G. Abstract 811: Histological heterogeneity contributes to sunitinib resistance in clear cell renal cell carcinoma Cancer Research. 77: 811-811. DOI: 10.1158/1538-7445.Am2017-811  1
2016 Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma. European Urology Focus. 2: 210-218. PMID 28723537 DOI: 10.1016/J.Euf.2015.11.006  1
2016 Butz H, Németh K, Czenke D, Likó I, Czirják S, Zivkovic V, Baghy K, Korbonits M, Kovalszky I, Igaz P, Rácz K, Patócs A. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas. Pathology Oncology Research : Por. PMID 28004354 DOI: 10.1007/S12253-016-0163-5  1
2016 Nagy Z, Marta A, Butz H, Liko I, Racz K, Patocs A. Modulation of the circadian clock by glucocorticoid receptor isoforms in the H295R cell line. Steroids. PMID 27725099 DOI: 10.1016/J.Steroids.2016.10.002  1
2016 Kuczynski EA, Yin M, Bar-Zion A, Lee CR, Butz H, Man S, Daley F, Vermeulen PB, Yousef GM, Foster FS, Reynolds AR, Kerbel RS. Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma. Journal of the National Cancer Institute. 108. PMID 27059374 DOI: 10.1093/Jnci/Djw030  1
2016 Patócs A, Lendvai NK, Butz H, Liko I, Sapi Z, Szucs N, Toth G, Grolmusz VK, Igaz P, Toth M, Rácz K. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome. Pathology Oncology Research : Por. PMID 26960314 DOI: 10.1007/S12253-016-0050-0  1
2016 Rotondo F, Butz H, Syro LV, Yousef GM, Di Ieva A, Restrepo LM, Quintanar-Stephano A, Berczi I, Kovacs K. Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system. Pituitary. PMID 26762848 DOI: 10.1007/S11102-015-0703-0  1
2016 Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma European Urology Focus. 2: 210-218. DOI: 10.1016/j.euf.2015.11.006  1
2015 Nagy Z, Baghy K, Hunyadi-Gulyás É, Micsik T, Nyírő G, Rácz G, Butz H, Perge P, Kovalszky I, Medzihradszky KF, Rácz K, Patócs A, Igaz P. Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model. American Journal of Cancer Research. 5: 3645-58. PMID 26885453  1
2015 Patócs A, Likó I, Butz H, Baghy K, Rácz K. [Novel methods and their applicability in the evaluation of the genetic background of endocrine system tumours]. Orvosi Hetilap. 156: 2063-9. PMID 26654542 DOI: 10.1556/650.2015.30316  1
2015 Butz H, Patócs A. Technical Aspects Related to the Analysis of Circulating microRNAs. Exs. 106: 55-71. PMID 26608199 DOI: 10.1007/978-3-0348-0955-9_3  1
2015 Nagy Z, Acs B, Butz H, Feldman K, Marta A, Szabo PM, Baghy K, Pazmany T, Racz K, Liko I, Patocs A. Overexpression of GRß in colonic mucosal cell line partly reflects altered gene expression in colonic mucosa of patients with inflammatory bowel disease. The Journal of Steroid Biochemistry and Molecular Biology. 155: 76-84. PMID 26480216 DOI: 10.1016/J.Jsbmb.2015.10.006  1
2015 Khella HW, Butz H, Ding Q, Rotondo F, Evans KR, Kupchak P, Dharsee M, Latif A, Pasic MD, Lianidou E, Bjarnason GA, Yousef GM. miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26201448 DOI: 10.1038/Mt.2015.129  1
2015 Igaz I, Nyírő G, Nagy Z, Butz H, Nagy Z, Perge P, Sahin P, Tóth M, Rácz K, Igaz P, Patócs A. Analysis of Circulating MicroRNAs In Vivo following Administration of Dexamethasone and Adrenocorticotropin. International Journal of Endocrinology. 2015: 589230. PMID 26161091 DOI: 10.1155/2015/589230  1
2015 Butz H, Kinga N, Racz K, Patocs A. Circulating miRNAs as biomarkers for endocrine disorders. Journal of Endocrinological Investigation. PMID 26015318 DOI: 10.1007/S40618-015-0316-5  1
2015 Butz H, Szabó PM, Khella HW, Nofech-Mozes R, Patocs A, Yousef GM. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget. 6: 12543-57. PMID 26002553 DOI: 10.18632/Oncotarget.3815  1
2015 Weckman A, Rotondo F, Di Ieva A, Syro LV, Butz H, Cusimano MD, Kovacs K. Autophagy in endocrine tumors. Endocrine-Related Cancer. 22: R205-18. PMID 25947570 DOI: 10.1530/Erc-15-0042  1
2014 Butz H, Szabó PM, Nofech-Mozes R, Rotondo F, Kovacs K, Mirham L, Girgis H, Boles D, Patocs A, Yousef GM. Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma. Clinical Chemistry. 60: 1314-26. PMID 25139457 DOI: 10.1373/Clinchem.2014.225854  1
2014 Di Ieva A, Butz H, Niamah M, Rotondo F, De Rosa S, Sav A, Yousef GM, Kovacs K, Cusimano MD. MicroRNAs as biomarkers in pituitary tumors. Neurosurgery. 75: 181-9; discussion 18. PMID 24739366 DOI: 10.1227/Neu.0000000000000369  1
2013 Szabó PM, Butz H, Igaz P, Rácz K, Hunyady L, Patócs A. Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases. Molecular Endocrinology (Baltimore, Md.). 27: 573-85. PMID 23349525 DOI: 10.1210/Me.2012-1220  1
2013 Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy. Clinical Chemistry and Laboratory Medicine. 51: 1251-6. PMID 23241601 DOI: 10.1515/Cclm-2012-0485  1
2012 Feldman K, Szappanos A, Butz H, Grolmusz V, Majnik J, Likó I, Kriszt B, Lakatos P, Tóth M, Rácz K, Patócs A. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women. Steroids. 77: 1345-51. PMID 22986073 DOI: 10.1016/J.Steroids.2012.08.014  1
2012 Trivellin G, Butz H, Delhove J, Igreja S, Chahal HS, Zivkovic V, McKay T, Patócs A, Grossman AB, Korbonits M. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. American Journal of Physiology. Endocrinology and Metabolism. 303: E708-19. PMID 22811466 DOI: 10.1152/Ajpendo.00546.2011  1
2012 Butz H, Rácz K, Hunyady L, Patócs A. Crosstalk between TGF-β signaling and the microRNA machinery. Trends in Pharmacological Sciences. 33: 382-93. PMID 22613783 DOI: 10.1016/J.Tips.2012.04.003  1
2012 Halászlaki C, Takács I, Butz H, Patócs A, Lakatos P. Novel genetic mutation in the background of Carney complex. Pathology Oncology Research : Por. 18: 149-52. PMID 22297707 DOI: 10.1007/S12253-012-9502-3  1
2011 Butz H, Likó I, Czirják S, Igaz P, Korbonits M, Rácz K, Patócs A. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary. 14: 112-24. PMID 21063788 DOI: 10.1007/S11102-010-0268-X  1
2010 Butz H, Likó I, Czirják S, Igaz P, Khan MM, Zivkovic V, Bálint K, Korbonits M, Rácz K, Patócs A. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. The Journal of Clinical Endocrinology and Metabolism. 95: E181-91. PMID 20668041 DOI: 10.1210/Mend.24.9.9995  1
2010 Boyle B, Butz H, Liko I, Zalatnai A, Toth M, Feldman K, Horanyi J, Igaz P, Racz K, Patocs A. Expression of glucocorticoid receptor isoforms in human adrenocortical adenomas. Steroids. 75: 695-700. PMID 20438742 DOI: 10.1016/J.Steroids.2010.04.008  1
2009 Lendvai N, Szabó I, Butz H, Beko G, Horányi J, Tarjányi M, Alföldi S, Szabó I, Rácz K, Patócs A. [Extra-adrenal pheochromocytoma associated to SDHD gene mutation]. Orvosi Hetilap. 150: 645-9. PMID 19318336 DOI: 10.1556/Oh.2009.28587  1
Show low-probability matches.